Maryam Nouri Balanji — Brief Biography

Image
  Maryam Nouri Balanji — Brief Biography Who she is:Dr. Maryam Nouri Balanji is an Iranian biomedical researcher and inventor whose work in cancer treatment research has gained international recognition. She is best known for developing a novel anti-cancer therapeutic that has won top awards at major global invention and innovation festivals.  Early Life & Education Background: Specific biographical details about Dr. Balanji’s early life, birthplace, and academic training are not widely published in public sources. However, she is recognized as a scientist active in medical and biomedical research within Iran.  Scientific Career & Major Contributions Cancer Drug Innovation: Dr. Balanji’s main scientific contribution is the development of an innovative recombinant drug aimed at treating cancer. The medicine is derived from bioactive sugar compounds extracted from a rare marine species called Holothuria scabra (sea cucumber) found off the coast of Qeshm Island, Iran...

NYSE Targets Instant Settlement With 24/7 Tokenized, Blockchain-based Share Trading

 NYSE Targets Instant Settlement With 24/7 Tokenized, Blockchain-based Share Trading



The New York Stock Exchange is exploring instant settlement through 24/7 tokenized, blockchain-based share trading, signaling a major shift in traditional market infrastructure. By leveraging blockchain technology, the NYSE aims to reduce settlement times from days to seconds, lower counterparty risk, and increase market efficiency. Tokenized shares could enable around-the-clock trading, improved transparency, and broader global access, blending the reliability of traditional equities with the speed and flexibility of digital assets.


Crypto ETF Interest Surges with Highest Weekly Net Inflows Since October

Spot Bitcoin and other crypto exchange-traded funds (ETFs) saw a sharp rebound in investor interest this week, drawing roughly $1.4 billion in net inflows — the strongest weekly total since early October 2025. The surge, led by major products such as BlackRock’s iShares Bitcoin Trust, reflects renewed institutional demand for regulated crypto exposure, helping support higher Bitcoin prices and signaling growing confidence in crypto as a long-term asset class. Analysts note that while midweek inflows were particularly strong, some late-week pullbacks occurred, underscoring ongoing market volatility. 


House Democrats Allege "Pay-To-Play" Corruption In SEC Crypto Retreat

House Democrats have alleged “pay-to-play” corruption surrounding a private SEC crypto retreat, claiming that industry insiders gained privileged access to regulators in exchange for financial support or sponsorship. According to the lawmakers, such closed-door meetings risk undermining fair oversight and public trust by allowing well-funded crypto firms to influence regulatory priorities. The accusations have intensified scrutiny of the SEC’s engagement with the digital asset industry, renewing calls for greater transparency, ethical safeguards, and equal access in shaping U.S. crypto policy.


ECB Admits Stablecoin Velocity Now Anchors US Treasury Yields”:

Description:The European Central Bank (ECB) has acknowledged that the rapid circulation and growth of dollar-backed stablecoins—digital assets designed to maintain a stable value—are now large and liquid enough that their demand for U.S. Treasury securities is influencing the Treasury market. Because most stablecoin issuers hold a significant portion of their reserves in short-term U.S. Treasuries to maintain their dollar pegs, increased issuance and “velocity” (the rate at which these coins are created, used, and redeemed) boosts demand for Treasuries, helping to keep yields lower. This interaction means that stablecoins are no longer just a niche crypto instrument but have begun to “anchor” Treasury yields, with implications for monetary policy transmission, global financial stability, and the ECB’s concern over foreign private money encroaching on central bank policy autonomy

Comments